Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 10:52 PM
Ignite Modification Date: 2025-12-24 @ 10:52 PM
NCT ID: NCT01193569
Eligibility Criteria: Inclusion Criteria: * From 18 to 85 years of age * Evidence of proximal anterior circulation large vessel occlusion (TIMI 0-1/TICI 0-1)from CT Angiography. Target vessel occlusion may include the supra-clinoid segment of the ICA through the M1 segment of the MCA. * Presented with symptoms consistent with acute ischemic stroke within 8 hours of symptom onset. Patients who presented within 3 hours must be ineligible or refractory to IV rtPA therapy. * At time of enrollment, neurological deficit resulting in an NIH Stroke Scale (NIHSS) score \> 10 * Known core infarct volume assessed by CTP, CTA or DWI scans Exclusion Criteria: * History of stroke in the past 3 months. * Pre-existing neurological or psychiatric disease that could confound the study results such as a pre-stroke mRS score \>1 * Known severe allergy to contrast media * Uncontrolled hypertension (defined as systolic blood pressure \>185 mmHg or diastolic blood pressure \>110 mmHg) * CT evidence of the following conditions before enrollment: * Significant mass effect with midline shift * Evidence of intracranial hemorrhage * Treated with endovascular therapy for acute stroke * Life expectancy was thought to be less than 90 days prior to stroke due to non-stroke illness * Participation in another clinical investigation that could confound the evaluation of the study
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 85 Years
Study: NCT01193569
Study Brief:
Protocol Section: NCT01193569